[ Price : $8.95]
Octapharma USA withdraws two lots of Octagam 10% [immune globulin intravenous (human)] liquid preparation] that is labeled with lo...[ Price : $8.95]
FDA issues a Warning Letter to Magellan Diagnostics for modifying versions of two of its blood lead testing systems without the ag...[ Price : $8.95]
SCA Pharmaceuticals recalls all lots of several injectable products because there is a potential for them to contain microbial con...[ Price : $8.95]
FDA posts 51 product-specific guidances (32 new and 19 revised) describing the agencys current thinking and expectations on how to...[ Price : $8.95]
FDA says it is paying equal attention to medical device manufacturers struggling alongside drug makers in Puerto Rico as they work...[ Price : $8.95]
Federal Register notice: FDA announces an extension of the deadline to provide Logical Observation Identifiers Names and Codes for...[ Price : $8.95]
Federal Register notice: FDA classifies devices that detect and identify microbial pathogen nucleic acids in cerebrospinal fluid i...[ Price : $8.95]
Celgene discontinues its Phase 3 REVOLVE trial (CD-002) in Crohns disease and the extension trial (SUSTAIN, CD-004) that are both ...